Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for treatment-resistant functional dyspepsia
IRCT20120709010222N19Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in functional dyspepsia (FD) comparing Gabapentin with Placebo (2 arms). Primary endpoints: Diarrhea, Constipation and 3 more. Started Sep 2018; status: completed.
02
Drugs
gabapentin
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on IRCT20120709010222N19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120709010222N19.